The New York Times Company·Communication Services
The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com Website. The company also transmits articles, graphics, and photographs from The Times and other publications to approximately 1,500 newspapers, magazines, and websites; licenses electronic databases to resellers in the business, professional, and library markets; and offers magazine licensing, news digests, book development, and rights and permissions. In addition, it engages in the live events business, which hosts physical and virtual live events to connect audiences with journalists and outside thought leaders; direct-sold website, mobile application, podcast, email, and video advertisements, as well as digital advertising services; operates Wirecutter, a product review and recommendation products; develops mobile applications, including games and cooking products; prints and distributes products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York.
Communication Services
Publishing
5,900
1973-05-03
0.98

"Using AI to surveil our work violates our contract and creates a skewed, inaccurate picture of our members' work," said Benjamin Harnett, chair of the Tech Guild's Generative AI committee and a staff software engineer at The Times.

Consumer confidence fell in May as inflation fears rose; Atmos Energy, CMS Energy, New York Times and Tyson Foods offer defense.

ASCO 2026: 2.5-Year Overall Survival Data Jefferies Healthcare Conference: Partnering & Investor meetings BIO International Convention: Panel Participation MIB Agents Factor Osteosarcoma Conference: Data Presentation New York, New York and Rockville, Maryland--(Newsfile Corp. - May 26, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, listeria-based cancer immunotherapies, announced that it will attend upcoming medical, financial and scientific conferences: American Society of Clinical Oncologists 2026 Where: Chicago, ILWhen: May 29, 2026 to June 2, 2026What: 2.5-year overall survival data announcement Jefferies Global Healthcare Conference 2026 Where: New York, NYWhen: June 2, 2026 to June 4, 2026What: Partnering meetings and select investor meetings BIO International Convention 2026 Where: San Diego, CAWhen: June 22, 2026 to June 25, 2026What: Partnering meetings and panel participation - "ADCs: How can we make bringing ADCs to market a faster, simpler, and more collaborative process?" MIB Agents: Factor Osteosarcoma Conference 2026 Where: Columbus, OHWhen: June 25, 2026 to June 27, 2026What: Data Presentation About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.

Fed rate hike fears and rising inflation from oil prices put NYT, TSN and ARKO in focus as defensive picks.

U.S. oil major Exxon Mobil is in talks to acquire rights to produce oil in Venezuela nearly two decades after it was effectively expelled from the country, the New York Times reported on Thursday, citing people familiar with the matter.

EL, NYT, ADM, TSN and FMX are gaining momentum as consumer staples stocks join Wall Street's 2026 rally.